Entera Bio Ltd (ENTX) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $1.51
• Market Cap: $72.45M
• EPS: $-0.24
• 52-Week High: $3.22
• 52-Week Low: $1.00

Market Sentiment

Entera Bio Ltd currently has a Bullish sentiment score of 0.27.

About Entera Bio Ltd

Entera Bio Ltd. (ENTX) is a clinical-stage biopharmaceutical company headquartered in Jerusalem, Israel, that is pioneering innovative oral delivery systems for large molecule therapeutics. Focusing on substantial unmet medical needs, the company leverages its proprietary platform to enhance patient compliance and broaden therapeutic options. Entera Bio's promising pipeline features advanced therapies designed to improve the efficacy and accessibility of treatments, thus positioning the compa...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Entera Bio Ltd and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does ENTX pay dividends?

Entera Bio Ltd (ENTX) does not currently pay a regular dividend.

What is ENTX's market cap?

Entera Bio Ltd (ENTX) has a market capitalization of $72.45M with a current stock price of $1.51.